Items where Author is "Jenei, Kristina"
Number of items: 17.
Article
Trends in time to withdrawal and full approval of accelerated approval cancer drug indications (1992–2024). (2025)
Jenei, Kristina and Hahn, Georg and Kesselheim, Aaron S. and Tibau, Ariadna
picture_as_pdf
The delicate balancing act of accelerated approval for cancer medicines—speed, certainty, and benefit. (2025)
Jenei, Kristina and Booth, Christopher M.
picture_as_pdf
The political economy of the World Health Organization model lists of essential medicines. (2025)
Jenei, Kristina
picture_as_pdf
WHO shapes priorities for medicines? An analysis of the applicants and decision makers within the historical evolution of the WHO Model Lists of Essential Medicines. (2024)
Jenei, Kristina and Glaus, Camille E.G. and Vokinger, Kerstin N.
picture_as_pdf
Clinical benefit, reimbursement outcomes, and prices of FDA-approved cancer drugs reviewed through Project Orbis in the USA, Canada, England, and Scotland:a retrospective, comparative analysis. (2024)
Jenei, Kristina and Gentilini, Arianna and Haslam, Alyson and Prasad, Vinay
picture_as_pdf
Assessment of price and clinical benefit of cancer drugs in Canada, 2011-2020.
Jenei, Kristina and Meyers, Daniel and Gyawali, Bishal
Characteristics of clinician input in Canadian funding decisions for cancer drugs:a cross-sectional study based on CADTH reimbursement recommendations.
Jenei, Kristina and Meyers, Daniel
picture_as_pdf
Conflict of interest disclosure in oncology:preliminary insights from the Global ONCOTRUST-1 cross-sectional study.
El Bairi, Khalid and Najem, Salma and Chowdhury, Arman Reza and Omar, Abeid and Abdihamid, Omar and Teuwen, Laure-Anne and Benhima, Nada and Madariaga, Ainhoa and Elkefi, Safa and Diaz, Fernando Cristobal and Hussain, Sadaqat and Jenei, Kristina and Hammad, Nazik and Mutebi, Miriam and Rubagumya, Fidel and Trapani, Dario and El Kadmiri, Nadia and Laouali, Nasser and Fourtassi, Maryam
picture_as_pdf
Depicting oncologists' perceptions and knowledge of global disparities in conflicts of interest reporting:the ONCOTRUST-1 study.
El Bairi, Khalid and Najem, Salma and Chowdhury, Arman Reza and Omar, Abeid and Abdihamid, Omar and Teuwen, Laure-Anne Marie Nicole and Benhima, Nada and Madariaga, Ainhoa and Elkefi, Safa and Diaz, Fernando Cristobal and Hussain, Sadaqat and Jenei, Kristina and Hammad, Nazik and Mutebi, Miriam Claire and Rubagumya, Fidel and Trapani, Dario and El Kadmiri, Nadia and Laouali, Nasser and Fourtassi, Maryam
GRADE Concept 7:issues and insights linking guideline recommendations to trustworthy essential medicine lists.
Piggott, Thomas and Moja, Lorenzo and Jenei, Kristina and Kredo, Tamara and Skoetz, Nicole and Banzi, Rita and Trapani, Dario and Leong, Trudy and McCaul, Michael and Lavis, John N. and Akl, Elie A. and Nonino, Francesco and Iorio, Alfonso and Laurson-Doube, Joanna and Huttner, Benedikt D. and Schünemann, Holger J.
picture_as_pdf
Globalisation of clinical trials in oncology:a double-edged sword?
Jenei, Kristina and Moraes, Fabio Y. and Gyawali, Bishal
picture_as_pdf
Health technology assessment for cancer medicines across the G7 countries and Oceania:an international, cross-sectional study.
Jenei, Kristina and Raymakers, Adam J.N. and Bayle, Arnaud and Berger-Thürmel, Karin and Cherla, Avi and Honda, Kazunori and Jackson, Christopher C.G.A. and Karikios, Deme and Trapani, Dario and Berry, Scott and Gyawali, Bishal
In pursuit of parity:addressing gender disparities in global cancer research.
Jenei, Kristina
picture_as_pdf
Measuring access to essential medicines in the sustainable development goals.
Jenei, Kristina and Wirtz, Veronika J.
picture_as_pdf
Price and clinical benefit of cancer drugs in Canada, 2011-2020.
Jenei, Kristina and Meyers, Daniel and Gyawali, Bishal
picture_as_pdf
Shortages of essential cancer medicines:who is responsible and what are the possible solutions?
Jenei, Kristina and Lythgoe, Mark P. and Vokinger, Kerstin N.
picture_as_pdf